PRMT3 and hepatocellular carcinoma: Lei's research discovered significant upregulation of PRMT3 in hepatocellular carcinoma (HCC) and proved that PRMT3 facilitates glycolysis and HCC growth by enhancing arginine methylation of LDHA, serving as a potential biomarker for HCC patient prognosis [68].